» Articles » PMID: 38082346

Hypoxia-mimetic by CoCl2 Increases SLC7A5 Expression in Breast Cancer Cells in Vitro

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2023 Dec 12
PMID 38082346
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Increased expression of the amino acid transporter solute Carrier Family 7 Member 5 (SLC7A5) has been observed in neoplastic cells during hypoxic conditions in vitro, indicating an adaptation for cell survival. To further explore this, we evaluated hypoxia-mimetic by CoCl2 as a model for hypoxia in breast cancer cell lines and the effect on SLC257A5 expression. Four different breast cancer cell lines (MCF7, T-47D, BT-474 and ZR-75-1) were exposed to 100 µM CoCl for 48 h. Subsequently, cell viability, gene- and protein expression analyses were performed.

Results: The gene expression of VEGF, a marker of hypoxia, was significantly elevated in all four cell lines compared to the control (p < 0.0001), indicating that CoCl exposure generates a hypoxic response. Moreover, CoCl exposure significantly upregulated SLC7A5 gene expression in T-47D (p < 0.001), BT-474 (p < 0.0001) and ZR-75-1 (p < 0.0001) cells, as compared to vehicle control. Immunofluorescence staining showed increased SLC7A5 protein expression in MCF7, T-47D and BT-474 cells compared to vehicle control. This report suggests that hypoxia-mimetic by CoCl can be used as a simple model for inducing hypoxia in breast cancer cell lines and in fact influence SLC7A5 gene and protein expression in vitro.

Citing Articles

Nobiletin: a potential erythropoietin receptor activator protects renal cells against hypoxia.

Liu N, Sun Y, Liu J, Zhang Y, Yi X, Yan W Apoptosis. 2025; .

PMID: 39755823 DOI: 10.1007/s10495-024-02067-9.


Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis.

Yoon M, Chun H, Lee H, Seo W, Lee J, Yoon J Cancer Med. 2024; 13(23):e70460.

PMID: 39628390 PMC: 11615507. DOI: 10.1002/cam4.70460.

References
1.
Hayashi K, Jutabha P, Endou H, Anzai N . c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells. Oncol Rep. 2012; 28(3):862-6. DOI: 10.3892/or.2012.1878. View

2.
Sato M, Harada-Shoji N, Toyohara T, Soga T, Itoh M, Miyashita M . L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism. Sci Rep. 2021; 11(1):589. PMC: 7803739. DOI: 10.1038/s41598-020-80668-5. View

3.
Li Q, Ma R, Zhang M . CoCl increases the expression of hypoxic markers HIF-1α, VEGF and CXCR4 in breast cancer MCF-7 cells. Oncol Lett. 2018; 15(1):1119-1124. PMC: 5769392. DOI: 10.3892/ol.2017.7369. View

4.
Lee H, Leslie F, Azarin S . A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl. J Biol Eng. 2018; 12:12. PMC: 6091074. DOI: 10.1186/s13036-018-0106-7. View

5.
Lee J, Bae S, Jeong J, Kim S, Kim K . Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med. 2004; 36(1):1-12. DOI: 10.1038/emm.2004.1. View